Saturday, July 25, 2026

pharma · Schizophrenia · Narcolepsy Type 1

Alkermes Pharma Ireland

Alkermes Pharma Ireland trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

Dublin, USA HQ
27 Employees
EMA registrant Type
Company details
Status
Public
HQ
Dublin, USA
Employees
27
Programs
1
Drugs
1
Patents
1
Intelligence · Clinical Trials

Alkermes Pharma Ireland clinical trials

Registry index of 1 ClinicalTrials.gov studies linked to Alkermes Pharma Ireland programs — each row shows trial ID, program name, phase, status, and indication.

Alkermes Pharma Ireland trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

1 updates

Latest clinical program signals indexed for Alkermes Pharma Ireland.

  1. ALKS 9072, Low Dose — Phase 3

    Clinical update

Trial registry

1 studies